Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      Health Canada places restrictions on Allergan Fibroid treatment Esmya

      Health Canada places restrictions on Allergan Fibroid treatment Esmya

      Farhat Nasim13 Jan 2019 9:00 AM IST
      The drug is sold in Europe by Hungarian drugmaker Richter. Richter has said it considered Esmya to be a safe and effective form of treatment.Canada:...
      Medical Representatives demand Minimum Wages of Rs 25,000, take to streets

      Medical Representatives demand Minimum Wages of Rs 25,000, take to streets

      Farhat Nasim12 Jan 2019 4:31 PM IST
      Bathinda: Demanding a fix minimum pay of Rs 25,000 and clearly defined timings of 8 hours of work each day, the Medical representatives ( MRs) in the...
      Hetero launches generic Lapatinib under the brand name HERTAB in India

      Hetero launches generic Lapatinib under the brand name HERTAB in India

      Farhat Nasim12 Jan 2019 12:14 PM IST
      HERTAB (Lapatinib) is an oral therapy indicated for the treatment of postmenopausal women with HER2-positive advanced breast cancer patients whose...
      Sun Pharma cheated of Rs 1.6 crore by two employees

      Sun Pharma cheated of Rs 1.6 crore by two employees

      Farhat Nasim11 Jan 2019 12:58 PM IST
      The duo used to falsify purchase orders and goods received memo (GRM) and reportedly duped the pharma major of Rs 1.6 croreVadodara: Drug major, Sun...
      Relief for J&J: Supreme court closes faulty hip implants case

      Relief for J&J: Supreme court closes faulty hip implants case

      Farhat Nasim11 Jan 2019 10:00 AM IST
      A bench comprising Chief Justice Ranjan Gogoi and Justice S K Kaul considered the response filed by the Union Health Ministry which said that a...
      Pharmaceutical Research: Constitution of Inter Departmental Committee to ensure transparency

      Pharmaceutical Research: Constitution of Inter Departmental Committee to ensure transparency

      Farhat Nasim11 Jan 2019 9:45 AM IST
      New Delhi: Plagued by allegations of lack of transparency, the government has decided to constitute an Inter Departmental Committee(IDC) to...
      J&J raises US prices on around two dozen drugs

      J&J raises US prices on around two dozen drugs

      Farhat Nasim11 Jan 2019 9:00 AM IST
      J&J joined many other companies that raised U.S. prices on hundreds of prescription medicines earlier this month.NEW YORK: Johnson & Johnson...
      No relief for Fixed Dose Combinations in Type 2 Diabetes: HC rejects pharma plea

      No relief for Fixed Dose Combinations in Type 2 Diabetes: HC rejects pharma plea

      Farhat Nasim10 Jan 2019 4:44 PM IST
      The Centre had banned the FDCs of the formulation of Metformin, Pioglitazone and Glimepiride of varying compositions. New Delhi: The Delhi High Court...
      Pfizer to shut shop at Chennai, Aurangabad units, 1700 employees in lurch

      Pfizer to shut shop at Chennai, Aurangabad units, 1700 employees in lurch

      Farhat Nasim10 Jan 2019 11:12 AM IST
      New Delhi: For more than 60 years of commercial and manufacturing presence in India, drug major Pfizer recently decided to shut down its...
      Lupin recalls over 23,000 bottles of Nitrofurantoin oral suspension in US

      Lupin recalls over 23,000 bottles of Nitrofurantoin oral suspension in US

      Farhat Nasim10 Jan 2019 9:45 AM IST
      As per the latest Enforcement Report issued by the USFDA, Lupin Somerset is recalling 23,460 bottles of Nitrofurantoin oral suspension which is used...
      Neuroshield: In-Med Prognostics raises Rs 50 lakh from BIRAC

      Neuroshield: In-Med Prognostics raises Rs 50 lakh from BIRAC

      Farhat Nasim10 Jan 2019 9:30 AM IST
      Pune: With an aim to bring affordable, accessible and evidence-based brain health diagnostic and prognostic tools to India and other emerging markets,...
      DoP Gazette on Price Cap Exemptions contrary to Health Ministry Expectations

      DoP Gazette on Price Cap Exemptions contrary to Health Ministry Expectations

      Farhat Nasim9 Jan 2019 5:57 PM IST
      New Delhi: The recent order passed by the Department of Pharmaceuticals (DoP) to exempt novel foreig-made drugs as well as orphan drugs from price...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok